Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome

Supportive Care in Cancer

Volumn 23, Issue 8, 2015, Pages 2215-2224

  Stafford, Lesley ^a,b   Judd, Fiona ^a,c   Gibson, Penny ^a   Komiti, Angela ^a,c   Mann, G Bruce ^c,d   Quinn, Michael ^a,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Royal Womens Hospital Melbourne   (Australia)

Author keywords

Anxiety; Cancer; Depression; Distress; Oncology

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; DEPRESSION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FEMALE GENITAL TRACT CANCER; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MORBIDITY; NEUROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TOBACCO USE; ADAPTIVE BEHAVIOR; ANXIETY; BREAST NEOPLASMS; GENITAL NEOPLASMS, FEMALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; AUSTRALIA; BREAST NEOPLASMS; DEPRESSION; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84933177844     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2571-y     Document Type: Article

References (42)

1. Australian Institute of Health (2012) Cancer in Australia: an overview 2012. AIHW, Canberra
2. Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011–1015
3. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10:19–28
4. Fowler JM, Carpenter KM, Gupta P, Golden-Kreutz DM, Andersen BL (2004) The gynecologic oncology consult: symptom presentation and concurrent symptoms of depression and anxiety. Obstet Gynecol 103:1211–1217
5. van Amstel FK P, van den Berg SW, van Laarhoven HW, Gielissen MF, Prins JB, Ottevanger PB (2013) Distress screening remains important during follow-up after primary breast cancer treatment. Support Care Cancer 21:2107–2115
6. Den Oudsten BL, Van Heck GL, Van der Steeg AF, Roukema JA, De Vries J (2009) Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psycho-Oncology 18:1230–1237
7. Manne S, Rini C, Rubin S, Rosenblum N, Bergman C, Edelson M et al (2008) Long-term trajectories of psychological adaptation among women diagnosed with gynecological cancers. Psychosom Med 70:677–687
8. Stafford L, Judd F, Gibson P, Komiti A, Mann G, Quinn M (2013) Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months. Psycho-Oncology 22:2071–2078
9. Lindviksmoen G, Hofso K, Paul SM, Miaskowski C, Rustoen T (2013) Predictors of initial levels and trajectories of depressive symptoms in women with breast cancer undergoing radiation therapy. Cancer Nurs 36:E34–E43
10. Johnson RL, Gold MA, Wyche KF (2010) Distress in women with gynecologic cancer. Psycho-Oncology 19:665–668
11. Enns A, Waller A, Groff SL, Bultz BD, Fung T, Carlson LE (2013) Risk factors for continuous distress over a 12-month period in newly diagnosed cancer outpatients. J Psychosoc Oncol 31:489–506
12. Torres MA, Pace TW, Liu T, Felger JC, Mister D, Doho GH et al (2013) Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer 119:1951–1959
13. Iwatani T, Matsuda A, Kawabata H, Miura D, Matsushima E (2013) Predictive factors for psychological distress related to diagnosis of breast cancer. Psycho-Oncology 22:523–529
14. Hulbert-Williams L, Neal RD, Morrison V, Hood K, Wilkinson C (2012) Anxiety, depression and quality of life after cancer diagnosis: what psychosocial variables best predict how patients adjust? Psycho-Oncology 21:857–867
15. Wong-Kim E, Bloom J (2005) Depression experienced by young women newly diagnosed with breast cancer. Psycho-Oncology 14:564–573
16. Kim JM, Jang JE, Stewart R, Kim SY, Kim SW, Kang HJ et al (2013) Determinants of suicidal ideation in patients with breast cancer. Psycho-Oncology 22:2848–2856
17. Van Esch L, Roukema JA, Ernst MF, Nieuwenhuijzen GA, De Vries J (2012) Combined anxiety and depressive symptoms before diagnosis of breast cancer. J Affect Disord 136:895–901
18. Osborn R, Demoncada A, Feuerstein M (2006) Psychosocial interventions for depression, anxiety and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36:13–34
19. Weiss A, Costa PT Jr (2005) Domain and facet personality predictors of all-cause mortality among Medicare patients aged 65 to 100. Psychosom Med 67:724–733
20. Watson D, Pennebaker J (1989) Health complaints, stress and distress: exploring the central role of negative affectivity. Psychol Rev 96:234–254
21. Krueger R, Caspi A, Moffitt T, Silva P, McGee R (1996) Personality traits are differentially linked to mental disorders: a multi-trait multi-diagnosis study of an adolescent birth cohort. J Abnorm Psychol 105:299–312
22. Scott J, Eccleston D, Boys R (1992) Can we predict the persistence of depression? Br J Psychiatry 161:633–637
23. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370
24. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77
25. Radloff LS (1977) The CESD scale: a self report scale for research in the general population. Appl Psychol Meas 1:385–401
26. Mitchell AJ, Meader N, Davies E, Clover K, Carter GL, Loscalzo MJ et al (2012) Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord 140:149–160
27. Luckett T, Butow PN, King MT, Oguchi M, Heading G, Hackl NA et al (2010) A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 18:1241–1262
28. Mulrow C, William J, Gerety M, Ramirez G, Montiel O, Kerber C (1995) Case-finding instruments for depression in primary care settings. Ann Intern Med 122:913–921
29. Goldberg L (2001) International personality item pool. www.ipip.ori.org
30. Gow A, Whiteman M, Pattie A, Deary I (2005) Goldberg’s ‘IPIP’ Big-Five factor markers: internal consistency and concurrent validation in Scotland. Personal Individ Differ 39:317–329
31. Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191
32. Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S et al (2012) Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol 124:389–394
33. Hoey LM, Ieropoli SC, White VM, Jefford M (2008) Systematic review of peer-support programs for people with cancer. Patient Educ Couns 70:315–337
34. Hartl K, Engel J, Herschbach P, Reinecker H, Sommer H, Friese K (2010) Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psycho-Oncology 19:160–169
35. Linden W, Girgis A (2012) Psychological treatment outcomes for cancer patients: what do meta-analyses tell us about distress reduction? Psycho-Oncology 21:343–350
36. Greer J, Pirl W, Park E, Lynch TJ, Temel J (2008) Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 65:549–552
37. Carlson LE, Bultz BD Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes 1:8
38. Satin J, Linden W, Phillips M (2009) Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115:5349–5361
39. Cuijpers P, Smit F, Penninx BW, de Graaf R, ten Have M, Beekman AT (2010) Economic costs of neuroticism: a population-based study. Arch Gen Psychiatry 67:1086–1093
40. Tamagawa R, Garland S, Vaska M, Carlson LE (2012) Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome. J Behav Med 35:658–673
41. Nakaya N, Hansen PE, Schapiro IR, Eplov LF, Saito-Nakaya K, Uchitomi Y et al (2006) Personality traits and cancer survival: a Danish cohort study. Br J Cancer 95:146–152
42. Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG et al (2000) Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. Eur J Cancer 36:1488–1497